Citron Research Updates Emcore (EMKR)
Tweet
Share
E-mailGet Alerts EMKR Hot Sheet
Join SI Premium – FREE
Today, Citron Research updated its opinion of Emcore (Nasdaq: EMKR). Citron is a widely followed short seller who has written negative pieces on Arthrocare (Nasdaq: ARTC), Home Solutions (OTCBB: HSOA) and others in the past. Ostensibly, his next target is Emcore.
Citron said Emcore is reminiscent of Home Solutions. Home Solutions now trades for under a $1. Citron believes that Emcore needs to become profitable to fix its problems.
Also, Citron said, if Emcore's Green and Gold Energy is revealed to be an 'empty shell,' Citron said Emcore would in turn miss its earnings. [JT]
Citron Research
Sign up at EasyStockAlerts.com & Make Money Today!
The Disciplined Investor - Essential Strategies for Success
Citron said Emcore is reminiscent of Home Solutions. Home Solutions now trades for under a $1. Citron believes that Emcore needs to become profitable to fix its problems.
Also, Citron said, if Emcore's Green and Gold Energy is revealed to be an 'empty shell,' Citron said Emcore would in turn miss its earnings. [JT]
Citron Research
Sign up at EasyStockAlerts.com & Make Money Today!
The Disciplined Investor - Essential Strategies for Success
You May Also Be Interested In
- Micron earnings preview: Can the AI boom keep the momentum going?
- Carnival Q3 results seen pressured by fuel costs, demand in focus
- B. Riley is bullish on this travel stock after Meta Muse partnership
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
